期刊论文详细信息
Memórias do Instituto Oswaldo Cruz
HPV vaccination: the beginning of the end of cervical cancer? - A Review
Ana Paula Lepique1  Tatiana Rabachini1  Luisa Lina Villa1 
[1] ,Instituto Ludwig de Pesquisa sobre o CâncerSão Paulo SP ,Brasil
关键词: human papillomavirus;    anogenital cancers;    prophylactic vaccine;    therapeutic vaccine;    clinical trial;   
DOI  :  10.1590/S0074-02762009000100001
来源: SciELO
PDF
【 摘 要 】

Human papillomavirus (HPV) is responsible for all cases of cervical cancer, as well as a great percentage of other anogenital tumors and oropharyngeal tumors. Since the main etiologic factor for these diseases is a virus, prophylactic measures are the best way to reduce the burden caused by the infection and associated disease. This review brings up to date information on the two commercially available prophylactic HPV vaccines against HPV, as well as presenting the ongoing research on HPV peptide, protein and dendritic cell based therapeutic vaccines.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License

【 预 览 】
附件列表
Files Size Format View
RO202005130047499ZK.pdf 382KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:21次